Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Cell Membrane-Coated Magnetic Nanocubes with a Homotypic Targeting Ability Increase Intracellular Temperature due to ROS Scavenging and Act as a Versatile Theranostic System for Glioblastoma Multiforme.

Tapeinos C, Tomatis F, Battaglini M, Larrañaga A, Marino A, Telleria IA, Angelakeris M, Debellis D, Drago F, Brero F, Arosio P, Lascialfari A, Petretto A, Sinibaldi E, Ciofani G.

Adv Healthc Mater. 2019 Aug 7:e1900612. doi: 10.1002/adhm.201900612. [Epub ahead of print]

PMID:
31389193
2.

Automated lesion segmentation with BIANCA: Impact of population-level features, classification algorithm and locally adaptive thresholding.

Sundaresan V, Zamboni G, Le Heron C, Rothwell PM, Husain M, Battaglini M, De Stefano N, Jenkinson M, Griffanti L.

Neuroimage. 2019 Jul 31;202:116056. doi: 10.1016/j.neuroimage.2019.116056. [Epub ahead of print]

3.

Lifespan normative data on rates of brain volume changes.

Battaglini M, Gentile G, Luchetti L, Giorgio A, Vrenken H, Barkhof F, Cover KS, Bakshi R, Chu R, Sormani MP, Enzinger C, Ropele S, Ciccarelli O, Wheeler-Kingshott C, Yiannakas M, Filippi M, Rocca MA, Preziosa P, Gallo A, Bisecco A, Palace J, Kong Y, Horakova D, Vaneckova M, Gasperini C, Ruggieri S, De Stefano N; MAGNIMS Study Group.

Neurobiol Aging. 2019 May 22;81:30-37. doi: 10.1016/j.neurobiolaging.2019.05.010. [Epub ahead of print]

PMID:
31207467
4.

Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment.

Grillone A, Battaglini M, Moscato S, Mattii L, de Julián Fernández C, Scarpellini A, Giorgi M, Sinibaldi E, Ciofani G.

Nanomedicine (Lond). 2019 Mar;14(6):727-752. doi: 10.2217/nnm-2018-0436. Epub 2018 Dec 21.

5.

Piezoelectric barium titanate nanostimulators for the treatment of glioblastoma multiforme.

Marino A, Almici E, Migliorin S, Tapeinos C, Battaglini M, Cappello V, Marchetti M, de Vito G, Cicchi R, Pavone FS, Ciofani G.

J Colloid Interface Sci. 2019 Mar 7;538:449-461. doi: 10.1016/j.jcis.2018.12.014. Epub 2018 Dec 4.

PMID:
30537658
6.

Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy.

Tapeinos C, Marino A, Battaglini M, Migliorin S, Brescia R, Scarpellini A, De Julián Fernández C, Prato M, Drago F, Ciofani G.

Nanoscale. 2018 Dec 20;11(1):72-88. doi: 10.1039/c8nr05520c.

7.

The dilemma of benign multiple sclerosis: Can we predict the risk of losing the "benign status"? A 12-year follow-up study.

Razzolini L, Portaccio E, Stromillo ML, Goretti B, Niccolai C, Pastò L, Righini I, Prestipino E, Battaglini M, Giorgio A, De Stefano N, Amato MP.

Mult Scler Relat Disord. 2018 Nov;26:71-73. doi: 10.1016/j.msard.2018.08.011. Epub 2018 Aug 18.

PMID:
30237106
8.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

9.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

10.

Ultrasound-Activated Piezoelectric Nanoparticles Inhibit Proliferation of Breast Cancer Cells.

Marino A, Battaglini M, De Pasquale D, Degl'Innocenti A, Ciofani G.

Sci Rep. 2018 Apr 19;8(1):6257. doi: 10.1038/s41598-018-24697-1.

11.

Beyond One Hundred: A Cohort Analysis of Italian Centenarians and Semi-supercentenarians.

Caselli G, Battaglini M, Capacci G.

J Gerontol B Psychol Sci Soc Sci. 2018 Mar 26. doi: 10.1093/geronb/gby033. [Epub ahead of print]

PMID:
29590466
12.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

13.

A 3D Real-Scale, Biomimetic, and Biohybrid Model of the Blood-Brain Barrier Fabricated through Two-Photon Lithography.

Marino A, Tricinci O, Battaglini M, Filippeschi C, Mattoli V, Sinibaldi E, Ciofani G.

Small. 2018 Feb;14(6). doi: 10.1002/smll.201702959. Epub 2017 Dec 14.

PMID:
29239532
14.

SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.

Battaglini M, Jenkinson M, De Stefano N; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2018 Mar;39(3):1063-1077. doi: 10.1002/hbm.23828. Epub 2017 Dec 8.

PMID:
29222814
15.

Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability.

Giorgio A, Zhang J, Stromillo ML, Rossi F, Battaglini M, Nichelli L, Mortilla M, Portaccio E, Hakiki B, Amato MP, De Stefano N.

Front Neurol. 2017 Nov 14;8:608. doi: 10.3389/fneur.2017.00608. eCollection 2017.

16.

Preparation, Characterization, and Preliminary In Vitro Testing of Nanoceria-Loaded Liposomes.

Grillone A, Li T, Battaglini M, Scarpellini A, Prato M, Takeoka S, Ciofani G.

Nanomaterials (Basel). 2017 Sep 16;7(9). pii: E276. doi: 10.3390/nano7090276.

17.

Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.

Tapeinos C, Battaglini M, Ciofani G.

J Control Release. 2017 Oct 28;264:306-332. doi: 10.1016/j.jconrel.2017.08.033. Epub 2017 Aug 26. Review.

PMID:
28844756
18.

Multimodal partial volume correction: Application to [11C]PIB PET/MRI myelin imaging in multiple sclerosis.

Grecchi E, Veronese M, Bodini B, García-Lorenzo D, Battaglini M, Stankoff B, Turkheimer FE.

J Cereb Blood Flow Metab. 2017 Dec;37(12):3803-3817. doi: 10.1177/0271678X17712183. Epub 2017 Jun 1. Erratum in: J Cereb Blood Flow Metab. 2018 Jan 1;38(6):1120. J Cereb Blood Flow Metab. 2018 Jan 1;38(6):119.

19.

Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Carluccio MA, Di Donato I, Pescini F, Battaglini M, Bianchi S, Valenti R, Nannucci S, Franci B, Stromillo ML, De Stefano N, Inzitari D, Pantoni L, Nuti R, Federico A, Gonnelli S, Dotti MT.

Neurol Sci. 2017 Jul;38(7):1333-1336. doi: 10.1007/s10072-017-2900-2. Epub 2017 Apr 4.

PMID:
28378255
20.

The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression.

Mignarri A, Dotti MT, Federico A, De Stefano N, Battaglini M, Grazzini I, Galluzzi P, Monti L.

J Neurol. 2017 May;264(5):862-874. doi: 10.1007/s00415-017-8440-0. Epub 2017 Mar 21.

PMID:
28324197
21.

11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis.

Datta G, Colasanti A, Kalk N, Owen D, Scott G, Rabiner EA, Gunn RN, Lingford-Hughes A, Malik O, Ciccarelli O, Nicholas R, Nei L, Battaglini M, Stefano ND, Matthews PM.

J Nucl Med. 2017 Sep;58(9):1477-1482. doi: 10.2967/jnumed.116.187161. Epub 2017 Mar 16.

22.

The role of dentate nuclei in human oculomotor control: insights from cerebrotendinous xanthomatosis.

Rosini F, Pretegiani E, Mignarri A, Optican LM, Serchi V, De Stefano N, Battaglini M, Monti L, Dotti MT, Federico A, Rufa A.

J Physiol. 2017 Jun 1;595(11):3607-3620. doi: 10.1113/JP273670. Epub 2017 Mar 14.

23.

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.

De Stefano N, Giorgio A, Battaglini M, De Leucio A, Hicking C, Dangond F, Giovannoni G, Sormani MP.

Mult Scler. 2018 Feb;24(2):222-226. doi: 10.1177/1352458517690269. Epub 2017 Jan 31.

24.

A catechin nanoformulation inhibits WM266 melanoma cell proliferation, migration and associated neo-angiogenesis.

di Leo N, Battaglini M, Berger L, Giannaccini M, Dente L, Hampel S, Vittorio O, Cirillo G, Raffa V.

Eur J Pharm Biopharm. 2017 May;114:1-10. doi: 10.1016/j.ejpb.2016.12.024. Epub 2017 Jan 11.

PMID:
28088004
25.

Brain MRI atrophy quantification in MS: From methods to clinical application.

Rocca MA, Battaglini M, Benedict RH, De Stefano N, Geurts JJ, Henry RG, Horsfield MA, Jenkinson M, Pagani E, Filippi M.

Neurology. 2017 Jan 24;88(4):403-413. doi: 10.1212/WNL.0000000000003542. Epub 2016 Dec 16. Review.

26.

A Semiautomatic Method for Multiple Sclerosis Lesion Segmentation on Dual-Echo MR Imaging: Application in a Multicenter Context.

Storelli L, Pagani E, Rocca MA, Horsfield MA, Gallo A, Bisecco A, Battaglini M, De Stefano N, Vrenken H, Thomas DL, Mancini L, Ropele S, Enzinger C, Preziosa P, Filippi M.

AJNR Am J Neuroradiol. 2016 Nov;37(11):2043-2049. doi: 10.3174/ajnr.A4874. Epub 2016 Jul 21.

27.

BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities.

Griffanti L, Zamboni G, Khan A, Li L, Bonifacio G, Sundaresan V, Schulz UG, Kuker W, Battaglini M, Rothwell PM, Jenkinson M.

Neuroimage. 2016 Nov 1;141:191-205. doi: 10.1016/j.neuroimage.2016.07.018. Epub 2016 Jul 9.

28.

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis.

Bodini B, Veronese M, García-Lorenzo D, Battaglini M, Poirion E, Chardain A, Freeman L, Louapre C, Tchikviladze M, Papeix C, Dollé F, Zalc B, Lubetzki C, Bottlaender M, Turkheimer F, Stankoff B.

Ann Neurol. 2016 May;79(5):726-738. doi: 10.1002/ana.24620.

29.

Long-term assessment of no evidence of disease activity in relapsing-remitting MS.

De Stefano N, Stromillo ML, Giorgio A, Battaglini M, Bartolozzi ML, Amato MP, Sormani MP.

Neurology. 2015 Nov 10;85(19):1722-3. doi: 10.1212/WNL.0000000000002105. Epub 2015 Oct 14. No abstract available.

PMID:
26468405
30.

Quantification of [(11)C]PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography.

Veronese M, Bodini B, García-Lorenzo D, Battaglini M, Bongarzone S, Comtat C, Bottlaender M, Stankoff B, Turkheimer FE.

J Cereb Blood Flow Metab. 2015 Nov;35(11):1771-82. doi: 10.1038/jcbfm.2015.120. Epub 2015 Jun 10.

31.

Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.

De Stefano N, Stromillo ML, Giorgio A, Bartolozzi ML, Battaglini M, Baldini M, Portaccio E, Amato MP, Sormani MP.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):93-9. doi: 10.1136/jnnp-2014-309903. Epub 2015 Apr 22.

32.

Prognostic biomarkers of IFNb therapy in multiple sclerosis patients.

Baranzini SE, Madireddy LR, Cromer A, D'Antonio M, Lehr L, Beelke M, Farmer P, Battaglini M, Caillier SJ, Stromillo ML, De Stefano N, Monnet E, Cree BA.

Mult Scler. 2015 Jun;21(7):894-904. doi: 10.1177/1352458514555786. Epub 2014 Nov 12.

33.

Automated identification of brain new lesions in multiple sclerosis using subtraction images.

Battaglini M, Rossi F, Grove RA, Stromillo ML, Whitcher B, Matthews PM, De Stefano N.

J Magn Reson Imaging. 2014 Jun;39(6):1543-9.

PMID:
24987754
34.

Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts.

Rossi F, Battaglini M, Stromillo ML, Giorgio A, Federico A, De Stefano N.

Neurol Sci. 2014 Aug;35(8):1249-53. doi: 10.1007/s10072-014-1691-y. Epub 2014 Mar 2.

PMID:
24584635
35.

Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.

Giorgio A, Stromillo ML, Bartolozzi ML, Rossi F, Battaglini M, De Leucio A, Guidi L, Maritato P, Portaccio E, Sormani MP, Amato MP, De Stefano N.

Mult Scler. 2014 Feb;20(2):214-9. doi: 10.1177/1352458513494490. Epub 2013 Jul 22.

PMID:
23877971
36.

Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.

Stromillo ML, Giorgio A, Rossi F, Battaglini M, Hakiki B, Malentacchi G, Santangelo M, Gasperini C, Bartolozzi ML, Portaccio E, Amato MP, De Stefano N.

Neurology. 2013 Jun 4;80(23):2090-4. doi: 10.1212/WNL.0b013e318295d707. Epub 2013 May 1.

PMID:
23635962
37.

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.

Vrenken H, Jenkinson M, Horsfield MA, Battaglini M, van Schijndel RA, Rostrup E, Geurts JJ, Fisher E, Zijdenbos A, Ashburner J, Miller DH, Filippi M, Fazekas F, Rovaris M, Rovira A, Barkhof F, de Stefano N; MAGNIMS Study Group.

J Neurol. 2013 Oct;260(10):2458-71. doi: 10.1007/s00415-012-6762-5. Epub 2012 Dec 21. Review.

38.

Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.

Giorgio A, Battaglini M, Rocca MA, De Leucio A, Absinta M, van Schijndel R, Rovira A, Tintoré M, Chard D, Ciccarelli O, Enzinger C, Gasperini C, Frederiksen J, Filippi M, Barkhof F, De Stefano N; MAGNIMS Study Group.

Neurology. 2013 Jan 15;80(3):234-41. doi: 10.1212/WNL.0b013e31827debeb. Epub 2012 Dec 5.

PMID:
23223533
39.

Relevance of brain lesion location to cognition in relapsing multiple sclerosis.

Rossi F, Giorgio A, Battaglini M, Stromillo ML, Portaccio E, Goretti B, Federico A, Hakiki B, Amato MP, De Stefano N.

PLoS One. 2012;7(11):e44826. doi: 10.1371/journal.pone.0044826. Epub 2012 Nov 5.

40.

MRI correlates of disability in African-Americans with multiple sclerosis.

Howard J, Battaglini M, Babb JS, Arienzo D, Holst B, Omari M, De Stefano N, Herbert J, Inglese M.

PLoS One. 2012;7(8):e43061. doi: 10.1371/journal.pone.0043061. Epub 2012 Aug 10. Erratum in: PLoS One. 2013;8(6). doi: 10.1371/annotation/25df480c-60b5-43a3-b03c-4e97d6ee399c.

41.

Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis.

Popescu V, Battaglini M, Hoogstrate WS, Verfaillie SC, Sluimer IC, van Schijndel RA, van Dijk BW, Cover KS, Knol DL, Jenkinson M, Barkhof F, de Stefano N, Vrenken H; MAGNIMS Study Group.

Neuroimage. 2012 Jul 16;61(4):1484-94. doi: 10.1016/j.neuroimage.2012.03.074. Epub 2012 Mar 30.

PMID:
22484407
42.

Cortical lesions in radiologically isolated syndrome.

Giorgio A, Stromillo ML, Rossi F, Battaglini M, Hakiki B, Portaccio E, Federico A, Amato MP, De Stefano N.

Neurology. 2011 Nov 22;77(21):1896-9. doi: 10.1212/WNL.0b013e318238ee9b. Epub 2011 Nov 9.

PMID:
22076541
43.

Evaluating and reducing the impact of white matter lesions on brain volume measurements.

Battaglini M, Jenkinson M, De Stefano N.

Hum Brain Mapp. 2012 Sep;33(9):2062-71. doi: 10.1002/hbm.21344. Epub 2011 Aug 31.

PMID:
21882300
44.

Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.

Dalton CM, Bodini B, Samson RS, Battaglini M, Fisniku LK, Thompson AJ, Ciccarelli O, Miller DH, Chard DT.

Mult Scler. 2012 Mar;18(3):322-8. doi: 10.1177/1352458511420269. Epub 2011 Aug 30.

PMID:
21878451
45.

Modelling the distribution of cortical lesions in multiple sclerosis.

Sormani M, Stromillo ML, Battaglini M, Signori A, De Stefano N.

Mult Scler. 2012 Feb;18(2):229-31. doi: 10.1177/1352458511414965. Epub 2011 Jul 14.

PMID:
21757533
46.

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.

Sbardella E, Tomassini V, Stromillo ML, Filippini N, Battaglini M, Ruggieri S, Ausili Cefaro L, Raz E, Gasperini C, Sormani MP, Pantano P, Pozzilli C, De Stefano N.

Mult Scler. 2011 Dec;17(12):1432-40. doi: 10.1177/1352458511414602. Epub 2011 Jul 5.

PMID:
21729978
47.

Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder.

Tavanti M, Battaglini M, Borgogni F, Bossini L, Calossi S, Marino D, Vatti G, Pieraccini F, Federico A, Castrogiovanni P, De Stefano N.

Neurol Sci. 2012 Feb;33(1):59-68. doi: 10.1007/s10072-011-0659-4. Epub 2011 Jun 28.

PMID:
21710131
48.

Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI.

Stromillo ML, Malandrini A, Dotti MT, Battaglini M, Borgogni F, Tessa A, Storti E, Denora PS, Santorelli FM, Gaudiano C, Battisti C, Federico A, De Stefano N.

J Neurol. 2011 Dec;258(12):2240-7. doi: 10.1007/s00415-011-6106-x. Epub 2011 May 29.

PMID:
21625935
49.

Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis.

De Stefano N, Stromillo ML, Rossi F, Battaglini M, Giorgio A, Portaccio E, Hakiki B, Malentacchi G, Gasperini C, Santangelo M, Bartolozzi ML, Sormani MP, Federico A, Amato MP.

PLoS One. 2011 Apr 29;6(4):e19452. doi: 10.1371/journal.pone.0019452.

50.

Magnetization transfer imaging demonstrates a distributed pattern of microstructural changes of the cerebral cortex in amyotrophic lateral sclerosis.

Cosottini M, Pesaresi I, Piazza S, Diciotti S, Belmonte G, Battaglini M, Ginestroni A, Siciliano G, De Stefano N, Mascalchi M.

AJNR Am J Neuroradiol. 2011 Apr;32(4):704-8. doi: 10.3174/ajnr.A2356. Epub 2011 Mar 24.

Supplemental Content

Loading ...
Support Center